نتایج جستجو برای: anastrozole

تعداد نتایج: 712  

Journal: :Anticancer research 2009
Martin Smollich Martin Götte Jeanett Fischgräbe Isabel Radke Ludwig Kiesel Pia Wülfing

BACKGROUND Estrogen receptors (ER) alpha and beta play an important role in breast cancer. Recently, systemic adjuvant endocrine therapy with selective estrogen receptor modulator (SERM) tamoxifen has been challenged by aromatase inhibitors. Compared to antiestrogens, third-generation aromatase inhibitors (anastrozole and letrozole) exhibit an improved efficacy and tolerability. MATERIALS AND...

2005
Gauri J. Sabnis Danijela Jelovac Brian Long Angela Brodie

To study the long-term effects of estrogen deprivation on breast cancer, MCF-7Ca human estrogen receptor–positive breast cancer cells stably transfected with human aromatase gene were cultured in the steroid-depleted medium for 6 to 8 months until they had acquired the ability to grow. Proliferation of these cells (UMB-1Ca) was accompanied by increased expression of human epidermal growth facto...

2015
Anya Rothenbuhler Agnès Linglart Pierre Bougnères

BACKGROUND When given during the course of puberty, anastrozole (A), an aromatase inhibitor, has been shown to increase the predicted adult height (PAH) of GH-deficient (GHD) boys treated with recombinant human growth hormone (rhGH). Our study questioned whether this treatment could retain some of its effects in non-GHD adolescent boys if started only at the very end of puberty, a time when rhG...

Journal: :Folia parasitologica 2007
Jitka Rudolfová D T J Littlewood Jiljí Sitko Petr Horák

In 2005, we dissected 102 wildfowl from the Czech Republic and 73 wildfowl from Poland including representatives of Anseriformes, Gruiformes and Gaviiformes. Schistosome infection was found in a total of 21 (29%) and 23 (23%) birds from Poland and the Czech Republic, respectively. All infected birds belonged to the order Anseriformes. The prevalences of nasal and visceral species were, respecti...

Journal: :Endocrine-related cancer 2004
Kellie L Jones Aman U Buzdar

Breast cancer is the most common carcinoma diagnosed in women today excluding non-melanoma skin cancers. It has been well documented that estrogen plays a critical role in its development and is a major target for treatment. For many years, tamoxifen has been the gold standard for adjuvant hormonal therapy in breast cancer patients. With newer products targeting different mechanisms to suppress...

Journal: :The Journal of toxicological sciences 2009
Makoto Shirai Ken Sakurai Wataru Saitoh Takuya Matsuyama Munehiro Teranishi Tadashi Furukawa Atsushi Sanbuissho Sunao Manabe

The main focus of this study was to determine the optimal administration period in terms of toxic effects on ovarian morphological changes. To assess the morphological and functional changes induced by anastrozole in ovaries, the compound was administered to female rats at dose levels or 0, 0.01, 0.1 and 50 mg/kg for 2 or 4 weeks in the repeated dose toxicity study and at levels of 0, 0.01, 0.1...

Journal: :Cancer research 2005
Gauri J Sabnis Danijela Jelovac Brian Long Angela Brodie

To study the long-term effects of estrogen deprivation on breast cancer, MCF-7Ca human estrogen receptor-positive breast cancer cells stably transfected with human aromatase gene were cultured in the steroid-depleted medium for 6 to 8 months until they had acquired the ability to grow. Proliferation of these cells (UMB-1Ca) was accompanied by increased expression of human epidermal growth facto...

Journal: :Frontiers in bioscience 2018
Nasimeh Yazdani Stacy Matthews Branch

Testosterone deficiency (TD) is a public health concern, a predictor of metabolic syndrome, and is associated with an increased all-cause and cardiovascular mortality. Testosterone deficiency in men is treated by a variety of methods including injectable testosterone compounds, patches, gels, pellets, and oral preparations. The use of testosterone alone has been linked to various adverse effect...

2013
Shaun Treweek Ruth Dryden Colin McCowan Alison Harrow Alastair Thompson

Results 33 breast cancer specialists ranked 39 trials in order of importance with the 12 most selected included in this study. Of 4811 women in the Tayside dataset, the number meeting eligibility criteria for the 12 trials ranged from 822 (17%) to 3419 (71%). Reasons for exclusion included age and comorbidity. Many women received a treatment evaluated in a trial but would themselves not have be...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید